Cost-Effectiveness of Genetic Testing for All Women Diagnosed with Breast Cancer in China

SIMPLE SUMMARY: Unselected multigene testing at breast cancer (BC) diagnosis has been reported to be cost-effective compared with family history (FH)/clinical-criteria-based testing in high-income countries such as the US and UK. Chinese patients are younger than Caucasian women at diagnosis, tendin...

Descripción completa

Detalles Bibliográficos
Autores principales: Sun, Li, Cui, Bin, Wei, Xia, Sadique, Zia, Yang, Li, Manchanda, Ranjit, Legood, Rosa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8997428/
https://www.ncbi.nlm.nih.gov/pubmed/35406611
http://dx.doi.org/10.3390/cancers14071839

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8997428/
https://www.ncbi.nlm.nih.gov/pubmed/35406611
http://dx.doi.org/10.3390/cancers14071839

Ejemplares similares